Item
SuperTab Ferrous Fumarate 95% DC (WE-201017)
Ferrous Fumarate, Acacia Gum
Mineral / Salt
Attributes
- Gluten-free
- Ingredient declaration
Locations
| Location name | Address |
|---|---|
| The Wright Group - Modesto, CA | 700 Kieran Ave Modesto, CA 95356 |
| WRIGHT PHARMA, INC. | 700 Kiernan Ave. Ste. A Modesto, CA 95356 |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens EU/UK | WRIGHT PHARMA, INC. | Allergens EU/UK.pdf | 4/21/2022 | 4/20/2024 |
| Allergens | WRIGHT PHARMA, INC. | Allergens.pdf | 3/22/2024 | 3/22/2026 |
| Country of Origin EU/UK | WRIGHT PHARMA, INC. | Country of Origin EU/UK.pdf | 4/21/2022 | 4/20/2025 |
| Country of Origin | WRIGHT PHARMA, INC. | Country of Origin.pdf | 3/21/2025 | 3/20/2028 |
| HACCP Process Flow Diagram | The Wright Group - Modesto, CA | Granulation System 1 Process Flow Chart-From Current WPI HACCP Plan 2021.pdf | 1/3/2024 | 1/2/2026 |
| HACCP | The Wright Group - Modesto, CA | Granulation System 1 Process Flow Chart-From Current WPI HACCP Plan 2021.pdf | 1/6/2025 | 1/6/2028 |
| HARPC Food Safety Plan (Item) | The Wright Group - Modesto, CA | Granulation System 1 Process Flow Chart-From Current WPI HACCP Plan 2021.pdf | 1/6/2025 | 1/6/2028 |
| National Bioengineered Food Disclosure Standard (Simplified) | WRIGHT PHARMA, INC. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 3/21/2025 | 3/20/2028 |
| Nutrition EU/UK | WRIGHT PHARMA, INC. | Nutrition EU/UK.pdf | 4/26/2022 | 4/25/2025 |
| Nutrition | WRIGHT PHARMA, INC. | Nutrition.pdf | 3/26/2025 | 3/25/2028 |
| CoA Sample | The Wright Group - Modesto, CA | WE Example CoA Min Only.pdf | 4/18/2024 | 4/18/2026 |
| BSE - TSE | WRIGHT PHARMA, INC. | WE-201017 BSE Statement.pdf | 4/22/2022 | 4/21/2025 |
| CoA Sample | WRIGHT PHARMA, INC. | WE-201017 COA.pdf | 5/18/2022 | 5/17/2024 |
| Product Specification Sheet | WRIGHT PHARMA, INC. | WE-201017 Ferrous Fumarate 95 DC.pdf | 4/21/2022 | 4/20/2025 |
| Gluten | WRIGHT PHARMA, INC. | WE-201017 Gluten Statement.pdf | 2/10/2025 | 2/10/2027 |
| GRAS/NDI/ODI Statement | WRIGHT PHARMA, INC. | WE-201017 GRAS Statement.pdf | 4/2/2025 | 4/1/2028 |
| Halal | WRIGHT PHARMA, INC. | WE-201017 Halal CA.pdf | 1/31/2023 | 1/31/2024 |
| Ingredient Statement | WRIGHT PHARMA, INC. | WE-201017 Ingredients Composition Range.pdf | 3/22/2023 | 3/21/2024 |
| Kosher | WRIGHT PHARMA, INC. | WE-201017 Kosher.pdf | 4/10/2023 | 4/30/2024 |
| GMO | WRIGHT PHARMA, INC. | WE-201017 Non-GMO Statement.pdf | 4/22/2022 | 4/21/2024 |
| EtO Statement | WRIGHT PHARMA, INC. | WE-201017 Organic Declaration.pdf | 4/22/2022 | 4/21/2024 |
| Irradiation Status Statement | WRIGHT PHARMA, INC. | WE-201017 Organic Declaration.pdf | 3/22/2024 | 3/22/2026 |
| Sewage Statement | WRIGHT PHARMA, INC. | WE-201017 Organic Declaration.pdf | 3/26/2024 | 3/26/2026 |
| Organic | WRIGHT PHARMA, INC. | WE-201017 Organic Declaration.pdf | 4/2/2025 | 4/2/2027 |
| California Prop. 65 | WRIGHT PHARMA, INC. | WE-201017 Prop 65 Statement.pdf | 3/22/2024 | 3/22/2026 |
| Pesticide | WRIGHT PHARMA, INC. | WE-201017 Residual Pesticide Statement.pdf | 4/26/2022 | 4/25/2024 |
| Residual Statement | WRIGHT PHARMA, INC. | WE-201017 Residual Solvent Statement.pdf | 3/29/2023 | 3/28/2024 |
| Safety Data Sheet (SDS) | WRIGHT PHARMA, INC. | WE-201017 SDS.pdf | 3/21/2025 | 3/20/2028 |
| Vegan/Vegetarian Statement | WRIGHT PHARMA, INC. | WE-201017 Vegan Statement.pdf | 4/2/2024 | 4/2/2026 |
| WADA/NSF/NFL Statement | WRIGHT PHARMA, INC. | WE-201017 WADA Statement.pdf | 4/27/2022 | 4/26/2024 |
